September 2026
The Power To Do
AI-Accelerated Cancer Breakthroughs
Speeding Up Drug Discovery With AI-Driven Modeling
What once took years of lab and computational work is now on a faster track at The University of Toledo.
UToledo’s Northwest Ohio Cancer Research Institute is deploying new artificial intelligence technology to help researchers identify promising drug candidates faster and with greater precision than traditional methods allowed. The Institute’s AI-Driven and Structure-Based Drug Discovery Core, directed by Dr. Jasmine Liu, is using a mix of laboratory techniques, computer modeling and AI tools to identify promising compounds for the treatment of for breast, pancreatic and prostate cancers.
The work reflects the clinical and research strengths of UToledo, which launched the Northwest Ohio Cancer Research Institute in 2026 to advance treatments for a pressing regional and national public health challenge.
Learn More
UToledo's Northwest Ohio Cancer Research Institute
More than 60 experts specializing in biology, chemistry, engineering, medicine, pharmacy and physics support the Northwest Ohio Cancer Research Institute, including more than 50 UToledo faculty whose active cancer research is supported by nearly $13 million in grants from federal agencies like the National Institutes of Health.
Learn More